Advertisement
Brief Report|Articles in Press

Changes in the Initiation of Antipsychotics and Trazodone Over Time: A Cohort Study of New Admissions to Nursing Homes in Ontario, Canada

  • Daniel A. Harris
    Correspondence
    Send correspondence and reprint requests to Daniel Harris, MPH, Division of Epidemiology, University of Toronto, 155 College St Rm 500, Toronto, ON M5T 3M7 Canada.
    Affiliations
    Division of Epidemiology, Dalla Lana School of Public Health (DAH, LCR, SEB), University of Toronto, Toronto, ON, Canada
    Search for articles by this author
  • Laura C. Maclagan
    Affiliations
    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada
    Search for articles by this author
  • Priscila Pequeno
    Affiliations
    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada
    Search for articles by this author
  • Andrea Iaboni
    Affiliations
    KITE Research Institute-Toronto Rehabilitation Institute (AI), University Health Network, Toronto, ON, Canada

    Department of Psychiatry (AI), University of Toronto, Toronto, ON, Canada
    Search for articles by this author
  • Peter C. Austin
    Affiliations
    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada

    Sunnybrook Research Institute (PCA, SEB), Toronto, ON, Canada

    Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health (PCA, SEB), University of Toronto, Toronto, ON, Canada
    Search for articles by this author
  • Laura C. Rosella
    Affiliations
    Division of Epidemiology, Dalla Lana School of Public Health (DAH, LCR, SEB), University of Toronto, Toronto, ON, Canada

    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada

    Institute for Better Health, Trillium Health Partners (LCR) , Mississauga, ON, Canada

    Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine (LCR), University of Toronto, Toronto, ON, Canada

    Vector Institute (LCR), Toronto, ON, Canada
    Search for articles by this author
  • Jun Guan
    Affiliations
    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada
    Search for articles by this author
  • Colleen J. Maxwell
    Affiliations
    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada

    Schools of Pharmacy and Public Health Sciences, University of Waterloo (CJM), Waterloo, ON, Canada
    Search for articles by this author
  • Susan E. Bronskill
    Affiliations
    Division of Epidemiology, Dalla Lana School of Public Health (DAH, LCR, SEB), University of Toronto, Toronto, ON, Canada

    ICES (LCM, PP, PCA, LCR, JG, CJM, SEB), Toronto, ON, Canada

    Sunnybrook Research Institute (PCA, SEB), Toronto, ON, Canada

    Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health (PCA, SEB), University of Toronto, Toronto, ON, Canada

    Women's College Research Institute (SEB), Women's College Hospital, Toronto, ON, Canada
    Search for articles by this author
Published:February 01, 2023DOI:https://doi.org/10.1016/j.jagp.2023.01.022

      Highlights

      • What is the primary question addressed by this study?
      • Following years of initiatives to reduce potentially inappropriate antipsychotic use in nursing homes, are there differences in the initiation of trazodone among newly admitted residents over time?
      • What is the main finding of this study?
      • Relative to those admitted in 2014 (a period associated with and leading up to several antipsychotic reduction efforts in Ontario, Canada), residents admitted prior (2010–2013) were more likely to be initiated on an antipsychotic, while residents admitted after (2015–2018) were less likely to be initiated on an antipsychotic.
      • Residents with dementia showed greater changes in medication initiation by year of admission, such that those admitted in the later period were more likely to be initiated on trazodone and less likely to be initiated on an antipsychotic compared to residents with dementia admitted in 2014.
      • What is the meaning of the finding?
      • Following efforts to reduce potentially inappropriate antipsychotic use in nursing homes, this study suggests a potential change to prescribing behavior over time, with trazodone possibly being initiated in lieu of antipsychotics for dementia symptoms.

      Abstract

      Objectives

      To investigate whether trazodone is being initiated in lieu of antipsychotics following antipsychotic reduction efforts, this study described changes in medication initiation over time.

      Methods

      We conducted a retrospective cohort study of new admissions to nursing homes in Ontario, Canada between April 2010 and December 2019 using health administrative data (N = 61,068). The initiation of antipsychotic and trazodone use was compared by year of admission using discrete time survival analysis and stratified by history of dementia.

      Results

      Relative to residents admitted in 2014, antipsychotic initiation significantly decreased in later years (e.g., 2017 admission year hazard odds ratio [HOR2017]=0.72 [95% confidence interval (95%CI)=0.62–0.82]) while trazodone initiation modestly increased (e.g., HOR2017=1.09 [95%CI=0.98–1.21]). The relative increase in trazodone initiation was larger among residents with dementia (e.g., HOR2017Dem =1.22 [95%CI=1.07–1.39]).

      Conclusions

      Differences in which medications were started following nursing home admission were observed and suggest trazodone may be initiated in lieu of antipsychotics.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Geriatric Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ivers NM
        • Taljaard M
        • Giannakeas V
        • et al.
        Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses.
        BMJ Qual Saf. 2019; 28: 121-131
        • Maust DT
        • Kim HM
        • Chiang C
        • et al.
        Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014.
        JAMA Intern Med. 2018; 178: 640-647
        • Iaboni A
        • Bronskill SE
        • Reynolds KB
        • et al.
        Changing pattern of sedative use in older adults: a population-based cohort study.
        Drugs Aging. 2016; 33: 523-533
        • Harris DA
        • Maclagan LC
        • Iaboni A
        • et al.
        Potential unintended consequences of antipsychotic reduction in Ontario nursing homes.
        J Am Med Dir Assoc. 2022; 23: 1066-1072.e7
        • Seitz DP
        • Adunuri N
        • Gill SS
        • et al.
        Antidepressants for agitation and psychosis in dementia.
        Cochr Databf Syst Rev. 2011; CD008191https://doi.org/10.1002/14651858.CD008191.pub2
        • Watt JA
        • Gomes T
        • Bronskill SE
        • et al.
        Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study.
        CMAJ. 2018; 190: E1376-E1383
        • Olivieri-Mui BL
        • Devlin JW
        • Ochoa A
        • et al.
        Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care.
        Aging Ment Health. 2018; 22: 544-549
        • Harris DA
        • Maclagan LC
        • Pequeno P
        • et al.
        Variation and correlation of potential unintended consequences of antipsychotic reduction in Ontario nursing homes over time.
        Med Care. 2023; 61: 173-181
        • Leong C
        • Enns MW
        • Sareen J
        • et al.
        New antidepressant use in older adults: a Canadian population-based study (1997-2013).
        Aging Mental Health. 2017; 21: 720-729
        • Bednarczyk E
        • Cook S
        • Brauer R
        • et al.
        Stakeholders' views on the use of psychotropic medication in older people: a systematic review.
        Age Ageing. 2022; 51afac060https://doi.org/10.1093/ageing/afac060
        • Davies SJ
        • Burhan AM
        • Kim D
        • et al.
        Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.
        J Psychopharmacol. 2018; 32: 509-523